日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/09/28 | 4,760 | 4,760 | 4,650 | 4,660 | -85 | -1.8% | 1,400 |
| 2018/09/27 | 4,770 | 4,800 | 4,745 | 4,745 | -95 | -2% | 3,000 |
| 2018/09/26 | 4,865 | 4,865 | 4,725 | 4,840 | -10 | -0.2% | 2,500 |
| 2018/09/25 | 4,780 | 4,850 | 4,710 | 4,850 | +135 | +2.9% | 4,300 |
| 2018/09/21 | 4,750 | 4,800 | 4,715 | 4,715 | -35 | -0.7% | 7,000 |
| 2018/09/20 | 4,650 | 4,750 | 4,650 | 4,750 | +25 | +0.5% | 3,900 |
| 2018/09/19 | 4,705 | 4,725 | 4,585 | 4,725 | +20 | +0.4% | 2,700 |
| 2018/09/18 | 4,605 | 4,705 | 4,605 | 4,705 | +100 | +2.2% | 1,700 |
| 2018/09/14 | 4,545 | 4,605 | 4,530 | 4,605 | +105 | +2.3% | 6,100 |
| 2018/09/13 | 4,470 | 4,505 | 4,455 | 4,500 | +30 | +0.7% | 2,500 |
| 2018/09/12 | 4,460 | 4,470 | 4,420 | 4,470 | -60 | -1.3% | 1,200 |
| 2018/09/11 | 4,550 | 4,555 | 4,530 | 4,530 | ±0 | ±0% | 1,200 |
| 2018/09/10 | 4,535 | 4,545 | 4,490 | 4,530 | +45 | +1% | 1,300 |
| 2018/09/07 | 4,505 | 4,505 | 4,440 | 4,485 | -20 | -0.4% | 800 |
| 2018/09/06 | 4,505 | 4,505 | 4,505 | 4,505 | +20 | +0.4% | 800 |
| 2018/09/05 | 4,555 | 4,555 | 4,485 | 4,485 | ±0 | ±0% | 700 |
| 2018/09/04 | 4,450 | 4,495 | 4,445 | 4,485 | -5 | -0.1% | 2,800 |
| 2018/09/03 | 4,430 | 4,500 | 4,430 | 4,490 | +55 | +1.2% | 400 |
| 2018/08/31 | 4,450 | 4,500 | 4,430 | 4,435 | -15 | -0.3% | 1,500 |
| 2018/08/30 | 4,470 | 4,470 | 4,435 | 4,450 | -20 | -0.4% | 500 |
| 2018/08/29 | 4,570 | 4,570 | 4,470 | 4,470 | -85 | -1.9% | 1,500 |
| 2018/08/28 | 4,570 | 4,600 | 4,530 | 4,555 | +55 | +1.2% | 500 |
| 2018/08/27 | 4,545 | 4,545 | 4,495 | 4,500 | +40 | +0.9% | 1,500 |
| 2018/08/24 | 4,460 | 4,460 | 4,460 | 4,460 | -30 | -0.7% | 200 |
| 2018/08/23 | 4,440 | 4,490 | 4,440 | 4,490 | +45 | +1% | 500 |
| 2018/08/22 | 4,480 | 4,480 | 4,445 | 4,445 | -50 | -1.1% | 500 |
| 2018/08/21 | 4,555 | 4,575 | 4,495 | 4,495 | -130 | -2.8% | 2,400 |
| 2018/08/20 | 4,625 | 4,625 | 4,625 | 4,625 | +70 | +1.5% | 300 |
| 2018/08/17 | 4,495 | 4,555 | 4,495 | 4,555 | +130 | +2.9% | 300 |
| 2018/08/16 | 4,450 | 4,450 | 4,420 | 4,425 | -40 | -0.9% | 1,600 |
| 2018/08/15 | 4,455 | 4,465 | 4,455 | 4,465 | +10 | +0.2% | 600 |
| 2018/08/14 | 4,545 | 4,545 | 4,450 | 4,455 | -20 | -0.4% | 1,300 |
| 2018/08/13 | 4,460 | 4,500 | 4,445 | 4,475 | +15 | +0.3% | 2,100 |
| 2018/08/10 | 4,535 | 4,535 | 4,410 | 4,460 | -30 | -0.7% | 6,900 |
| 2018/08/09 | 4,495 | 4,505 | 4,440 | 4,490 | -5 | -0.1% | 500 |
| 2018/08/08 | 4,595 | 4,595 | 4,485 | 4,495 | -110 | -2.4% | 900 |
| 2018/08/07 | 4,565 | 4,605 | 4,540 | 4,605 | +80 | +1.8% | 1,400 |
| 2018/08/06 | 4,435 | 4,600 | 4,420 | 4,525 | +70 | +1.6% | 3,600 |
| 2018/08/03 | 4,520 | 4,600 | 4,455 | 4,455 | -60 | -1.3% | 3,100 |
| 2018/08/02 | 4,540 | 4,545 | 4,510 | 4,515 | -25 | -0.6% | 2,200 |
| 2018/08/01 | 4,635 | 4,635 | 4,515 | 4,540 | -95 | -2% | 2,500 |
| 2018/07/31 | 4,765 | 4,765 | 4,515 | 4,635 | -140 | -2.9% | 2,700 |
| 2018/07/30 | 4,525 | 4,785 | 4,485 | 4,775 | +250 | +5.5% | 4,300 |
| 2018/07/27 | 4,450 | 4,525 | 4,450 | 4,525 | +55 | +1.2% | 1,200 |
| 2018/07/26 | 4,495 | 4,495 | 4,470 | 4,470 | +45 | +1% | 1,400 |
| 2018/07/25 | 4,445 | 4,455 | 4,425 | 4,425 | -15 | -0.3% | 2,200 |
| 2018/07/24 | 4,525 | 4,525 | 4,430 | 4,440 | -25 | -0.6% | 1,500 |
| 2018/07/23 | 4,455 | 4,515 | 4,455 | 4,465 | +10 | +0.2% | 1,900 |
| 2018/07/20 | 4,445 | 4,455 | 4,435 | 4,455 | -25 | -0.6% | 500 |
| 2018/07/19 | 4,410 | 4,480 | 4,410 | 4,480 | +70 | +1.6% | 500 |
1501～
1550
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
